Latest AI and machine learning research in chemotherapy for healthcare professionals.
Homologous recombination deficiency (HRD) is a critical biomarker in high-grade serous ovarian cancer for the clinical benefit from platinum-based chemotherapy and poly polymerase inhibitors, but molecular testing is costly, time-consuming, and limited by tissue requirements. In this study, we introduce dPathHRD (digital Pathological assessment of Homologous Recombination Deficiency), a deep learn...
BACKGROUND: T1 colorectal cancer (T1 CRC) is increasingly treated with curative-intent endoscopic resection, but tumor recurrence remains a critical f...
Lung cancer remains the leading cause of cancer-related incidence and mortality worldwide. Its tendency for postoperative distant metastasis significa...
We present a framework for data-efficient training of machine-learning interatomic potentials for interfacial chemistry, especially heterogeneous cata...
In the over-century-long history of colorectal tumor surgery, achieving organ function preservation has consistently been a central topic. Currently, ...
Sphincter-preserving therapy for low rectal cancer has always been a difficult and hot topic in colorectal cancer. Advanced understanding of the biolo...
Objective: This study processes and analyzes rectal MRI images of patients with mid-to-low rectal cancer using deep learning technology, and integrate...
Conventional tumor chemotherapy faces limitations including drug resistance, high toxicity, non-selectivity, and side effects. Nano-drug delivery syst...
The management of nasopharyngeal carcinoma (NPC), a malignancy with pronounced geographic prevalence in Southeast Asia, is undergoing a paradigm shift...
Cell viability assays are essential tools in biomedical research and drug development. Artificial intelligence (AI) offers the potential to simplify t...
OBJECTIVE: This study aimed to develop a machine learning model based on ultrasonography (US) and clinicopathological features to predict pathological...
This study utilized a novel Proximity Barcoding Assay to perform high-resolution proteomic profiling of individual plasma extracellular vesicles from ...
Non-small cell lung cancer (NSCLC) patient management relies on molecular analysis to determine eligibility for targeted therapy. Furthermore, neoadju...
Histopathological hematoxylin and eosin (H&E) slides contain valuable prognostic information for pancreatic ductal adenocarcinoma (PDAC), yet systemat...
PURPOSE: Preoperative assessment of pathologic complete response (pCR) to neoadjuvant therapy is an urgent need for anorectal preservation in patients...
BACKGROUND: Data on neoadjuvant treatment with trastuzumab biosimilars, particularly CT-P6, in combination with pertuzumab, are limited. This study ev...
Heavy and essential metals coexist in a cell, collectively participate in cellular biological processes, and lead to overall health consequences. Howe...